Listen Top Shows Blog

EHRA-PATHS Randomized trial: aim and importance

EHRA-PATHS Randomized trial: aim and importance

Update: 2024-09-26

Share

Description

With Isabelle van Gelder, Michiel Rienstra and Michelle Lobeek, University Medical Centre Groningen - The Netherlands, and Prash Sanders, University of Adelaide - Australia.

In this episode of Cardio Talk Latest Research, Isabelle van Gelder interviews Michiel Rienstra, Michelle Lobeek and Prash Sanders about the EHRA-PATHS clinical trial, which focuses on improving the quality of life for patients with atrial fibrillation and comorbidities. They discuss the clinical trial's design, methodology, and implementation in detail.

This podcast was recorded in April 2024.

Comments

In Channel

EHRA-PATHS: The rationale (and pain) of a clinical trial with new software to tackle comorbidities in AF

EHRA-PATHS: The rationale (and pain) of a clinical trial with new software to tackle comorbidities in AF

2025-09-1510:53

AI4HF and the future of cardiology: how federated analysis is transforming cardiovascular research

AI4HF and the future of cardiology: how federated analysis is transforming cardiovascular research

2025-08-1711:49

NextGen and the Future of Cardiology: Innovation, Insights, and the Road Ahead

NextGen and the Future of Cardiology: Innovation, Insights, and the Road Ahead

2025-07-0911:19

AI4HF: Leveraging health informatics and epidemiologic data and methods for AI-based risk prediction and early intervention

AI4HF: Leveraging health informatics and epidemiologic data and methods for AI-based risk prediction and early intervention

2025-05-2712:20

AI4HF: Artificial intelligence implementation and implications in clinical practice

AI4HF: Artificial intelligence implementation and implications in clinical practice

2024-10-2412:06

EHRA-PATHS Randomized trial: aim and importance

EHRA-PATHS Randomized trial: aim and importance

2024-09-2608:38

AI4HF: Breaking Language Barriers in Healthcare: Exploring Multi-Lingual LLMs

AI4HF: Breaking Language Barriers in Healthcare: Exploring Multi-Lingual LLMs

2024-09-1910:41

CARDIOCARE: cardiotoxicity in elderly breast cancer patients

CARDIOCARE: cardiotoxicity in elderly breast cancer patients

2024-09-1210:34

CORE-MD: Medical device registries for post-market surveillance

CORE-MD: Medical device registries for post-market surveillance

2024-09-0511:09

CORE-MD: How do surgeons choose which medical device to implant?

CORE-MD: How do surgeons choose which medical device to implant?

2024-08-2912:11

CORE-MD: Real-world evidence on the performance of high-risk medical devices

CORE-MD: Real-world evidence on the performance of high-risk medical devices

2024-08-2211:52

CORE-MD: Providing medical devices for children

CORE-MD: Providing medical devices for children

2024-08-1513:23

CORE-MD: Understanding how notified bodies work in the European Union

CORE-MD: Understanding how notified bodies work in the European Union

2024-08-0812:27

00:00

00:00

1.0x

EHRA-PATHS Randomized trial: aim and importance

EHRA-PATHS Randomized trial: aim and importance

European Society of Cardiology